Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients
Clinical trial NCT03961009 · COMPLETED
Trial details
- NCT number
- NCT03961009
- Sponsor
- Kedrion S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2020-12-21
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.